Date published: 2026-5-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

TADA3L Activators

TADA3L, also known as Transcriptional Adaptor 3-Like, is a protein involved in transcriptional regulation and chromatin remodeling. As direct activators of TADA3L are not well-established, the focus shifts to chemicals that can indirectly influence its activity through the modulation of related pathways or cellular processes. The primary class of compounds listed here includes histone deacetylase (HDAC) inhibitors. These compounds, such as Trichostatin A, SAHA (Vorinostat), RGFP966, M344, Entinostat, Scriptaid, Panobinostat, Sodium Butyrate, Valproic Acid, Romidepsin, and Belinostat, function by inhibiting the activity of histone deacetylases. Histone deacetylases are enzymes that remove acetyl groups from histone proteins, leading to chromatin condensation and reduced transcriptional activity. By inhibiting these enzymes, HDAC inhibitors cause an increase in histone acetylation, leading to a more relaxed chromatin structure and enhanced transcription of various genes. This change in the transcriptional landscape can indirectly affect proteins like TADA3L, which are involved in transcriptional regulation and chromatin organization.

Another class of compounds is DNA methyltransferase inhibitors, represented by 5-Azacytidine. This compound inhibits DNA methyltransferases, enzymes responsible for adding methyl groups to DNA, which usually results in gene silencing. By inhibiting these enzymes, 5-Azacytidine can lead to demethylation of DNA and subsequent activation of previously silenced genes. This alteration in gene expression can indirectly impact the function and regulation of proteins like TADA3L.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor, it can lead to changes in gene expression that might indirectly affect TADA3L activity.

RGFP966

1357389-11-7sc-507300
5 mg
$115.00
(0)

Selective histone deacetylase 3 inhibitor, potentially altering the expression of genes in the TADA3L network.

M 344

251456-60-7sc-203124
sc-203124A
1 mg
5 mg
$109.00
$322.00
8
(1)

A potent HDAC inhibitor, which could indirectly influence TADA3L through epigenetic modifications.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

An HDAC inhibitor that can modify gene expression, possibly affecting TADA3L-related pathways.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Histone deacetylase inhibitor that affects chromatin remodeling and gene expression, potentially influencing TADA3L activity.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

An HDAC inhibitor that can modulate gene expression and potentially affect TADA3L-related pathways.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$218.00
$634.00
1
(1)

A cyclic peptide HDAC inhibitor, which could have an indirect effect on TADA3L through changes in gene expression.